Analyst Ratings for Pharming Group (PHAR)

PHAR Rating Summary

PHAR Price Target Summary

* Over Last 12-Mos
  |   Expand Research on PHAR
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: $39.50 (+155.8%) * Over Last 12-Mos
Rating Score: 10 / 10   Percentile Rank: 95%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
12/9/2024 Jefferies Lucy Codrington New Coverage Buy
(N/A)
14.00
(N/A)
7.56
(15.44)
104.23% Details